Oncologists Accepting Curative
2,173 verified oncologists across the U.S. accept Curative. Profiles cover focus areas including Medical Oncology, Hematology & Oncology, and Thoracic Oncology. Common hospital affiliations include Memorial Sloan Kettering Cancer Center, Hospital for Special Surgery, and University of Texas MD Anderson Cancer Center.
Andrew Zelenetz, MD
Medical Director, Quality Informatics; Attending Physician, Lymphoma Service; Professor of Medicine, Weill Cornell Medicine
Oncology
Mark Kris, MD
Attending Physician, Thoracic Oncology Service; William and Joy Ruane Chair in Thoracic Oncology; Professor of Medicine, Weill Cornell Medical College
Oncology
Shreyaskumar Patel, MD
Tenured Professor of Medicine, Robert R. Herring Distinguished Professor of Cancer Research, Medical Director of the Sarcoma Center
Oncology
Frank Fossella, M.D.
Associate Medical Director, Department of Thoracic/Head and Neck Medical Oncology; Professor of Medicine and Internist
Oncology
Deborah Armstrong, M.D.
Professor of Oncology, Professor of Gynecology and Obstetrics; Director, Breast and Ovarian Surveillance Service
Oncology
Eric Jonasch, M.D.
Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Oncology
Ursula Matulonis, MD
Professor of Medicine, Harvard Medical School; Chief and Director, Division of Gynecologic Oncology, Dana-Farber Cancer Institute
Oncology
Robert Haddad, MD
Chief, Division of Head and Neck Oncology; McGraw Chair in Head and Neck Oncology; Professor of Medicine, Harvard Medical School
Oncology
Carol Aghajanian, MD
Chief, Gynecologic Medical Oncology Service; Avon Chair in Gynecologic Oncology Research; Professor of Medicine, Weill Cornell Medical College
Oncology
Patrick Ott, MD
Professor of Medicine, Harvard Medical School; Clinical Director, Melanoma Disease Center; Director, Clinical Sciences, Center for Immuno-Oncology; Senior Physician
Oncology
Sattva Neelapu, M.D.
Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Oncology
Kenneth Anderson, MD
Kraft Family Professor of Medicine, Harvard Medical School; Director, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute
Oncology
Mary-Ellen Taplin, MD
Professor of Medicine, Harvard Medical School; Institute Physician and Director of Clinical Research, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Oncology
Kelly Hunt, M.D.
Professor & Chair, Department of Breast Surgical Oncology; Professor, Department of Surgical Oncology
Oncology
Jeffrey Gershenwald, M.D.
Dr. John M. Skibber Endowed Professor, Department of Surgical Oncology; Medical Director, Melanoma and Skin Center; Professor, Department of Cancer Biology
Oncology
Al Iii, MD
Professor, Medicine (Hematology and Oncology), Feinberg School of Medicine
Oncology
William Gradishar, MD
Betsy Bramsen Professor of Breast Oncology; Director, Maggie Daley Center for Women's Cancer Care; Professor, Medicine (Hematology and Oncology)
Oncology
Laurence Rhines, M.D.
Professor and Director of the Spine Tumor Program, Department of Neurosurgery
Oncology
Toni Choueiri, M.D.
Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School
Oncology
Harry Erba, MD
Professor of Medicine, Duke University School of Medicine; Director, Leukemia Program; Director, Phase I Development in Hematologic Malignancies
Oncology
Oncologists accepting Curative by state
Find oncologists who accept Curative in your state.